- Jun 22, 2021 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Role: 10%+ Owner
Signature: Danaher Corporation /s/ James F. O'Reilly, Vice President, Deputy General Counsel and Secretary
Stock symbol: TBIO
Transactions as of: Jun 22, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/24/2021, 04:51 PM
Previous filing: Jun 24, 2021
Next filing: Sep 11, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TBIO	Common Stock	Conversion of derivative security	$0	+2.29M		$0.00	2.29M	Jun 22, 2021	By Danaher Innovation Center LLC	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TBIO	Series A Preferred Stock	Conversion of derivative security	$0	-1.75M	-100%	$0.00^*	0	Jun 22, 2021	Common Stock	1.75M		By Danaher Innovation Center LLC	F1, F2
transaction	TBIO	Series A-1 Preferred Stock	Conversion of derivative security	$0	-542K	-100%	$0.00^*	0	Jun 22, 2021	Common Stock	542K		By Danaher Innovation Center LLC	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Danaher Corp /De/ is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date.
F2	Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.

Content

Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date.

Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.